Schmid P - Search Results

1

Eosinophilia during fludarabine treatment of chronic lymphocytic leukemia.

Sezer O, Schmid P, Hallek M, Schweigert M, Beinert T, Langelotz C, Mergenthaler HG, Possinger K. Sezer O, et al. Among authors: schmid p. Ann Hematol. 1999 Oct;78(10):475-7. doi: 10.1007/s002770050602. Ann Hematol. 1999. PMID: 10550560 Review.

2

Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell support.

Sezer O, Schmid P, Shweigert M, Heider U, Eucker J, Harder H, Sinha P, Radtke H, Possinger K. Sezer O, et al. Among authors: schmid p. Bone Marrow Transplant. 1999 May;23(9):967-9. doi: 10.1038/sj.bmt.1701765. Bone Marrow Transplant. 1999. PMID: 10338056

3

Phase II trial of gemcitabine as prolonged infusion in metastatic breast cancer.

Schmid P, Akrivakis K, Flath B, Grosse Y, Sezer O, Mergenthaler HG, Possinger K. Schmid P, et al. Anticancer Drugs. 1999 Aug;10(7):625-31. doi: 10.1097/00001813-199908000-00001. Anticancer Drugs. 1999. PMID: 10507311 Clinical Trial.

4

New therapeutic approaches in primary systemic AL amyloidosis.

Sezer O, Eucker J, Schmid P, Possinger K. Sezer O, et al. Among authors: schmid p. Ann Hematol. 2000 Jan;79(1):1-6. doi: 10.1007/s002770050001. Ann Hematol. 2000. PMID: 10663614 Review.

5

Further evidence for oxidant-induced vascular endothelial growth factor up-regulation in the bronchoalveolar lavage fluid of lung cancer patients undergoing radio-chemotherapy.

Beinert T, Binder D, Oehm C, Ziemer S, Priem F, Stuschke M, Schweigert M, Siebert G, Mergenthaler HG, Schmid P, Fleischhacker M, Possinger K. Beinert T, et al. Among authors: schmid p. J Cancer Res Clin Oncol. 2000 Jun;126(6):352-6. doi: 10.1007/s004320050355. J Cancer Res Clin Oncol. 2000. PMID: 10870646

6

Prolonged infusion of gemcitabine in stage IV breast cancer: a phase I study.

Akrivakis K, Schmid P, Flath B, Schweigert M, Sezer O, Mergenthaler HG, Possinger K. Akrivakis K, et al. Among authors: schmid p. Anticancer Drugs. 1999 Jul;10(6):525-31. doi: 10.1097/00001813-199907000-00003. Anticancer Drugs. 1999. PMID: 10885899 Clinical Trial.

7

Detection of HMGI-C in the peripheral blood of breast cancer patients.

Sezer O, Langelotz C, Blohmer JU, Schmid P, Akrivakis K, Possinger K. Sezer O, et al. Among authors: schmid p. Eur J Cancer. 2000 Oct;36(15):1944-8. doi: 10.1016/s0959-8049(00)00199-4. Eur J Cancer. 2000. PMID: 11000575

8

[New therapeutic approaches in advanced breast carcinoma. Palliative measures are increasingly more tolerable].

Schmid P, Possinger K. Schmid P, et al. MMW Fortschr Med. 2000 Aug 31;142(35):22-4. MMW Fortschr Med. 2000. PMID: 11006699 German.

9

Achievement of complete remission in refractory Hodgkin's disease with prolonged infusion of gemcitabine.

Sezer O, Eucker J, Jakob C, Kaufmann O, Schmid P, Possinger K. Sezer O, et al. Among authors: schmid p. Invest New Drugs. 2001;19(1):101-4. doi: 10.1023/a:1006478702342. Invest New Drugs. 2001. PMID: 11291828

10

[Real uses or just no damage? Bisphosphonates in oncology].

Schmid P, Sezer O, Possinger K. Schmid P, et al. Pharm Unserer Zeit. 2001;30(6):519-28. doi: 10.1002/1615-1003(200111)30:6<519::AID-PAUZ519>3.0.CO;2-D. Pharm Unserer Zeit. 2001. PMID: 11715685 Review. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,516 results

Search Page

Filters